[HTML][HTML] Squamous rectal carcinoma: a rare malignancy, literature review and management recommendations

C Astaras, A Bornand, T Koessler - ESMO open, 2021 - Elsevier
Highlights•Rectal squamous cell carcinoma (rSCC) is a rare entity for which we have limited
knowledge and no clear recommendations.•Creation of an international registry and a …

[HTML][HTML] Primary squamous cell carcinoma of the rectum: an update and implications for treatment

GR Guerra, CH Kong, SK Warrier… - World journal of …, 2016 - ncbi.nlm.nih.gov
AIM: To provide an update on the aetiology, pathogenesis, diagnosis, staging and
management of rectal squamous cell carcinoma (SCC). METHODS: A systematic review …

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma

N Yang, L Xu, Q Wang, F Chen, Y Zhou - Cancer Medicine, 2022 - Wiley Online Library
Background Anal squamous cell carcinoma (ASCC) is the main subtype of anal cancer and
has great heterogeneity in prognosis. We aimed to construct a nomogram for predicting their …

Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?

AE Coghill, MS Shiels, RK Rycroft, G Copeland… - AIDS, 2016 - journals.lww.com
Objective: Squamous cell carcinoma (SCC) of the rectum is rare, but as with anal cancer,
risk may be increased among immunosuppressed individuals. We assessed risk of rectal …

Gemcitabine-based chemotherapy in colon squamous cell carcinoma: A case report and literature review

S Zhao, J Guo, L Sun, J Lv… - … and clinical oncology, 2017 - spandidos-publications.com
Squamous cell carcinoma (SCC) originating from the colon is rare. In terms of its
clinicopathological characteristics, this type of cancer has been reported to be more …

Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma

L Herve, S Kim, J Boustani, E Klajer, M Pernot… - Frontiers in …, 2022 - frontiersin.org
Background Advanced rectal squamous cell carcinoma (rSCC) is a very rare and aggressive
entity, and the best initial management is crucial for long survival as well as organ …

Is There an Association between a Tonsillar Diffuse Large B-Cell Lymphoma Arising after a Neck Squamous Cell Carcinoma of Occult Primary? A Case Report and …

D Tatsis, A Niakou, K Paraskevopoulos… - Hematology …, 2024 - mdpi.com
Objectives: The aim of this review is to focus on the possibility of patients with squamous cell
carcinoma to develop a second primary disease such as DLBCL, perhaps because of the …

[HTML][HTML] Synchronous and metachronous malignant epithelial and lymphoid tumors: a clinicopathologic study of 10 patients from a major tertiary care center in …

NU Din, Z Ahmad, K Minhas, Z Uddin… - Asian Pacific Journal of …, 2017 - ncbi.nlm.nih.gov
Case reports and case series documenting unfortunate patients with more than one
malignant neoplasm are rare but well established. While majority of such patients have two …

Synchronous Anal Squamous Cell Carcinoma and Diffuse Large B Cell Lymphoma of Stomach: the First Report of an Odd Couple

J Nath, M Neog, A Iqbal, A Sarma, D Khanikar… - Indian Journal of Surgical …, 2024 - Springer
The unique case study presented here explores an exceptionally rare occurrence in an HIV-
positive female—synchronous diagnoses of anal squamous cell carcinoma and diffuse large …

利妥昔单抗注射液联合化疗治疗B 细胞非霍奇金淋巴瘤的疗效观察.

周婕, 青胜兰, 徐锋, 张娜… - Progress in Modern …, 2015 - search.ebscohost.com
摘要目的: 观察利妥昔单抗注射液联合化疗治疗B 细胞非霍奇金淋巴瘤(B-NHL) 的疗效. 方法:
将2013 年1 月至2014 年12 月我院收治的71 例B-NHL 患者分为对照组(n= 35 例) 和观察组(n …